Skip to main content
. 2022 Mar 7;36(10):7486–7493. doi: 10.1007/s00464-022-09171-4

Table 3.

Clinicopathological features of the CSS and non-CSS groups

CSS, n = 174 Non-CSS, n = 130 p value
Age, mean (SD) 72.6 (8.6) 74.1 (7.6) 0.110
Gender, n (%) 1
 Male 103 (70.1) 94 (72.3)
 Female 44 (29.9) 36 (27.7)
Co-morbidity (/lesion)
 Atrial fibrillation 14 (8.0) 10 (7.7) 1
 Ischemic heart disease 5 (2.9) 7 (5.4) 0.373
 Cerebrovascular disease 11 (6.3) 11 (8.5) 0.508
 Chronic kidney disease on HD 3 (1.7) 1 (0.8) 0.638
Antithrombotic agent therapy, n (%) (/lesion)
 Aspirin 12 (6.9) 12 (7.1) 0.521
 Thienopyridine derivatives 12 (6.9) 8 (6.2) 1
 Cilostazol 8 (4.6) 2 (1.5) 0.198
 Warfarin 5 (2.9) 3 (2.3) 1
 DOAC 18 (10.3) 8 (6.2) 0.220
 others 11 (6.3) 13 (10.0) 0.284
Antithrombotic agent use, n (%) 53 (30.5) 39 (30.0) 1
 Single 41 (23.6) 31 (23.8) 1
 Doublet 9 (5.2) 6 (4.6) 1
 Triplet 2 (1.1) 1 (0.8) 1
Heparin replacement 10 (5.7) 5 (3.8) 0.595
P-CAB 18 (10.3) 20 (15.4) 0.221
Tumor location, n (%)
 Lower third 75 (43.1) 69 (53.1) 0.104
 Middle third 65 (37.4) 38 (29.2) 0.144
 Upper third 34 (19.5) 22 (16.9) 0.654
Macroscopic type, n (%)
 Elevated 72 (41.4) 65 (50.0) 0.162
 Flat/depressed 81 (46.6) 57 (43.8) 0.644
 Mixed 21 (12.1) 8 (6.2) 0.113
Histology
 Adenoma 44 (25.3) 14 (10.8) 0.002
 Differentiated type 123 (70.7) 110 (84.6) 0.006
 Undifferentiated type 7 (4.0) 6 (4.6) 0.784
UL (+), n (%) 15 (8.6) 8 (6.2) 0.513
Depth
 SM2, n (%) 8 (4.6) 8 (6.2) 0.609
Resection size, mm(mean ± SD) 37.2 (12.9) 36.8 (12.4) 0.808
Resection size > 30 mm, n (%) 115 (66.1) 82 (63.1) 0.628
Tumor size, mm(mean ± SD) 17.4 (11.6) 15.6 (10.7) 0.177
Resection time, minutes(mean ± SD) 112.0 (74.5) 92.1 (65.2) 0.015
Resection time > 100 min, n (%) 81 (46.6) 44 (33.8) 0.034
En bloc resection, n (%) 167 (96.0) 128 (98.5) 0.309
R0 resection, n (%) 161 (92.5) 125 (96.2) 0.225
Intraoperative perforation, n (%) 5 (2.9) 0 (0) 0.074